SCHOTT Pharma AG & Co. KGaA (XTRA:1SXP) Price Target Increased by 5.38% to 34.72

The average one-year price target for SCHOTT Pharma AG & Co. KGaA (XTRA:1SXP) has been revised to 34.72 / share. This is an increase of 5.38% from the prior estimate of 32.95 dated January 16, 2024.

The price target is an average of many targets provided by analysts. The latest targets range from a low of 30.30 to a high of 44.10 / share. The average price target represents a decrease of 9.59% from the latest reported closing price of 38.40 / share.

SCHOTT Pharma AG & Co. KGaA Maintains 0.39% Dividend Yield

At the most recent price, the company's dividend yield is 0.39%.

What is the Fund Sentiment?

There are 27 funds or institutions reporting positions in SCHOTT Pharma AG & Co. KGaA. This is an increase of 20 owner(s) or 285.71% in the last quarter. Average portfolio weight of all funds dedicated to 1SXP is 0.38%, an increase of 50.22%. Total shares owned by institutions increased in the last three months by 559.66% to 3,949K shares.

What are Other Shareholders Doing?

DE:1SXP / SCHOTT Pharma AG & Co. KGaA Shares Held by Institutions

PRITX - T. Rowe Price International Stock Fund holds 1,252K shares.

PRIDX - T. Rowe Price International Discovery Fund holds 876K shares.

LISOX - Lazard International Strategic Equity Portfolio Open Shares holds 510K shares.

LGGAX - ClearBridge International Growth Fund holds 384K shares.

SMCWX - SMALLCAP WORLD FUND INC holds 184K shares. In it's prior filing, the firm reported owning 2,100K shares, representing a decrease of 1,044.25%. The firm decreased its portfolio allocation in 1SXP by 91.26% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.